Real world outcomes of sequential ADC therapy in metastatic breast cancer: Patients treated with sacituzumab govitecan and trastuzumab deruxtecan

被引：0
|
作者：
Mai, Nicholas
Klar, Miriam
Ferraro, Emanuela
Bromberg, Maria
Chen, Yuan
Razavi, Pedram
Modi, Shanu
Chandarlapaty, Sarat
Walsh, Elaine M.
Drago, Joshua Z.
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA
[3] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1085
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Safety of trastuzumab deruxtecan and radiation therapy combination in HER2-positive metastatic breast cancer patients
    Visani, L.
    Ratosa, I.
    Ribnikar, D.
    Becherini, C.
    Bertini, N.
    Bonaparte, I.
    Stefanovski, D.
    Dobnikar, N.
    Desideri, I.
    Mattioli, C.
    Valzano, M.
    Banini, M.
    Salvestrini, V.
    Bernini, M.
    Tommasi, C.
    Nori, J.
    Orzalesi, L.
    Bianchi, S.
    Livi, L.
    Meattini, I.
    EUROPEAN JOURNAL OF CANCER, 2024, 200 : 60 - 61
  • [42] Evaluating risk factors for Trastuzumab-Deruxtecan Pneumonitis in patients with metastatic breast cancer
    Henricks, Jonathan
    Haddad, Tyler
    Ahmed, Omair
    Schoenhals, Jonathan
    Kumar, Pavnesh
    Wilson, Ryan
    Ma, Jianing
    Wang, Jing Gennie
    Wert, Michael
    Esguerra, Vincent
    Bentley, Ian
    Johnson, Kai
    Stover, Daniel
    Jhawar, Sachin R.
    Gatti-Mays, Margaret
    Ho, Kevin
    BREAST CANCER RESEARCH, 2025, 27 (01)
  • [43] SARELIFE: An Italian, multicentric real-world study of sacituzumab govitecan (SG) in pretreated metastatic triple-negative breast cancer (mTNBC)
    Cona, M. S.
    Ruggieri, L.
    Artale, S. A. A.
    Catania, G.
    D'Auria, G.
    Gallerani, E.
    Villa, F.
    Gambaro, A.
    Chirco, A.
    Giordano, M.
    Pistelli, M.
    Verderame, F.
    Bramati, A.
    Stani, S. C.
    Vici, P.
    Meattini, I.
    Tagliaferri, B.
    Tedesco, B.
    Amato, O.
    La Verde, N. M.
    ANNALS OF ONCOLOGY, 2024, 35 : S381 - S382
  • [44] Therapy for chemopretreated metastatic urothelial cancer (mUC) with the antibody-drug conjugate (ADC) sacituzumab govitecan (IMMU-132).
    Tagawa, Scott T.
    Ocean, Allyson J.
    Lam, Elaine Tat
    Saylor, Philip James
    Bardia, Aditya
    Hajdenberg, Julio
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [45] Monitoring and management of interstitial lung disease/pneumonitis among patients with metastatic breast cancer treated with trastuzumab deruxtecan.
    Kish, Jonathan K.
    Mehta, Sandhya
    Kwong, Jackie
    Lam, Clara
    Falkenstein, Angelica
    Brown-Bickerstaff, Cherrishe
    Xiao, Dong
    Feinberg, Bruce A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [46] Pre-treatment [18F]FDG PET biomarkers and clinical outcomes of patients with metastatic triple-negative breast cancer treated with Sacituzumab govitecan
    Seban, R.
    De Moura, A.
    Loirat, D.
    Bidard, F.
    Jehanno, N.
    Huchet, V.
    Genevee, T.
    Buvat, I.
    Champion, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S302 - S302
  • [47] Financial toxicity in patients with metastatic breast cancer on trastuzumab deruxtecan (T-DXd)
    Lapen, Kaitlyn
    Dee, Edward Christopher Christopher
    Thom, Bridgette
    Aviki, Emeline Mariam
    Chino, Fumiko
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [48] Sequential combination of sacituzumab govitecan and talazoparib in metastatic triple negative breast cancer (mTNBC): Results from a phase II study
    Abelman, Rachel Occhiogrosso
    Spring, Laura
    Niemierko, Andrzej
    Abraham, Elizabeth
    McNeice, Mary
    Goff, Jennifer
    Valenti, Amanda
    Wander, Seth Andrew
    Isakoff, Steven J.
    Moy, Beverly
    Juric, Dejan
    Vidula, Neelima
    Waks, Adrienne Gropper
    Parsons, Heather Anne
    Ellisen, Leif W.
    Tolaney, Sara M.
    Bardia, Aditya
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [49] Population Pharmacokinetics of Sacituzumab Govitecan in Patients with Metastatic Triple-Negative Breast Cancer and Other Solid Tumors
    Sathe, Abhishek G.
    Singh, Indrajeet
    Singh, Pratap
    Diderichsen, Paul M.
    Wang, Xiaohui
    Chang, Peter
    Taqui, Atiya
    Phan, See
    Girish, Sandhya
    Othman, Ahmed A.
    CLINICAL PHARMACOKINETICS, 2024, 63 (05) : 669 - 681
  • [50] Trastuzumab deruxtecan versus trastuzumab emtansine in Asian patients with HER2-positive metastatic breast cancer
    Iwata, Hiroji
    Xu, Binghe
    Kim, Sung-Bae
    Chung, Wei-Pang
    Park, Yeon Hee
    Kim, Min Hwan
    Tseng, Ling-Ming
    Chung, Chi-Feng
    Huang, Chiun-Sheng
    Kim, Jee Hyun
    Chiu, Joanne Wing Yan
    Yamashita, Toshinari
    Li, Wei
    Egorov, Anton
    Nishijima, Soichiro
    Nakatani, Shunsuke
    Nishiyama, Yuji
    Sugihara, Masahiro
    Cortes, Javier
    Im, Seock-Ah
    CANCER SCIENCE, 2024, 115 (09) : 3079 - 3088
12345